ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.711,48
-0,02%
Brent Oil
81,295
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSX
  6. Valeo Pharma Inc (VPH)

  7. Valeo Pharma Inc (VPH) Notícias

VPH

Valeo Pharma (VPH)

Valeo Pharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSX:VPH
DataHoraFonteTítuloCódigoCompanhia
25/04/202418:55PR Newswire (Canada)VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERSTSX:VPHValeo Pharma Inc
09/04/202408:00PR Newswire (Canada)VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCETSX:VPHValeo Pharma Inc
22/03/202408:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORSTSX:VPHValeo Pharma Inc
14/03/202418:29PR Newswire (Canada)VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTSTSX:VPHValeo Pharma Inc
07/03/202409:00PR Newswire (Canada)VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
13/02/202409:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES BOARD OF DIRECTORS CHANGESTSX:VPHValeo Pharma Inc
02/02/202419:03PR Newswire (Canada)VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LPTSX:VPHValeo Pharma Inc
29/01/202419:48PR Newswire (Canada)VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL YEAR 2023TSX:VPHValeo Pharma Inc
22/01/202409:00PR Newswire (Canada)VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
20/11/202309:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES ORGANIZATIONAL CHANGES AND COST REDUCTION INITIATIVESTSX:VPHValeo Pharma Inc
07/11/202309:15PR Newswire (Canada)VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORSTSX:VPHValeo Pharma Inc
04/10/202308:00PR Newswire (Canada)VALEO PHARMA MAKES THE LIST OF THE GLOBE AND MAIL'S FIFTH-ANNUAL RANKING OF CANADA'S TOP GROWING COMPANIESTSX:VPHValeo Pharma Inc
27/09/202308:00PR Newswire (Canada)VALEO PHARMA ENTERS INTO $5 MILLION CREDIT FACILITY AGREEMENT WITH ACCORD FINANCIAL INC.TSX:VPHValeo Pharma Inc
27/09/202308:00PR Newswire (Canada)VALEO PHARMA CONCLUT UNE ENTENTE DE FACILITÉ DE CRÉDIT DE 5 MILLIONS $ AVEC ACCORD FINANCIAL INC.TSX:VPHValeo Pharma Inc
13/09/202321:01PR Newswire (Canada)VALEO PHARMA ANNONCE DES REVENUS RECORDS POUR LE TROISIÈME TRIMESTRE DE 2023TSX:VPHValeo Pharma Inc
13/09/202320:44PR Newswire (Canada)VALEO PHARMA REPORTS RECORD THIRD QUARTER 2023 REVENUESTSX:VPHValeo Pharma Inc
07/09/202308:00PR Newswire (Canada)VALEO PHARMA TO HOST THIRD QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
31/08/202320:11PR Newswire (Canada)Investissement Québec conclut un placement privé dans Valeo Pharma Inc.TSX:VPHValeo Pharma Inc
31/08/202319:27PR Newswire (Canada)VALEO PHARMA CONCLUT UN FINANCEMENT DE 4,5 MILLIONS $TSX:VPHValeo Pharma Inc
31/08/202319:10PR Newswire (Canada)VALEO PHARMA CLOSES $4.5 MILLION FINANCINGTSX:VPHValeo Pharma Inc
22/06/202308:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTSTSX:VPHValeo Pharma Inc
07/06/202308:00PR Newswire (Canada)VALEO PHARMA TO HOST SECOND QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
25/05/202308:00PR Newswire (Canada)VALEO PHARMA PROVIDING GUIDANCE OF RECORD REVENUES FOR THE SECOND QUARTER 2023TSX:VPHValeo Pharma Inc
28/04/202308:43PR Newswire (Canada)VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS AND COMMITTEE APPOINTMENTSTSX:VPHValeo Pharma Inc
19/04/202308:00PR Newswire (Canada)VALEO PHARMA TO PRESENT AT THE 2023 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCETSX:VPHValeo Pharma Inc
15/03/202318:00PR Newswire (Canada)VALEO PHARMA REPORTS RECORD QUARTERLY REVENUES FOR THE FIRST QUARTER 2023TSX:VPHValeo Pharma Inc
09/03/202309:00PR Newswire (Canada)VALEO PHARMA TO HOST FIRST QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
07/02/202309:00PR Newswire (Canada)VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ONSTRYV® IN QUEBECTSX:VPHValeo Pharma Inc
26/01/202309:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES FILING OF A NEW DRUG SUBMISSION-COVID 19 WITH HEALTH CANADA FOR SABIZABULIN FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTSTSX:VPHValeo Pharma Inc
25/01/202311:38PR Newswire (Canada)VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2022 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
 Apresentando as notícias mais relevantes sobre:TSX:VPH

Seu Histórico Recente

TSX
QCLN
First Trust Nasdaq Clean...
TG
A28VQF
Airbus
EU
MLAEM
Ashler Et Manson
NASDAQ
FXYUBX
Ft Income Portfolio Seri...
USOTC
BKHPF
Bank Hapoalim (PK)
TSXV
FSW.H
Fireswirl Technologies
TSX
HHL.B
Harvest Healthcare Leade...
LSE
78IS
Ashtead 25
USOTC
ATEYY
Advantest (PK)
TSX
INCR.U
Intercure
BIT
P1ZV30
NLBNPIT1ZV30 20991231 31...
LSE
FM95
Mitsu Hc Cap.26
EU
CTEAB
Coentreprise de Transpor...
TSXV
NPR
North Peak Resources
USOTC
LEHLQ
Lehman Brothers (CE)
BOV
S1PL34R
Splunk
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados